ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Horizon Therapeutics plc Named to the Seramount Inclusion Index

--Company Recognized for Transparency and Best Practices Related to an Inclusive Culture--

Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has been named to Seramount’s (formerly Working Mother media) 2022 Inclusion Index. The Inclusion Index recognizes companies that commit to advancing diversity, equity and inclusion (DEI) and implement programming that supports an inclusive workplace.

“We are committed to nurturing an inclusive workplace where all employees feel welcome and thrive,” said Irina Konstantinovsky, executive vice president, chief human resources and chief diversity officer, Horizon. “It is an honor to be recognized on the Inclusion Index and we will continue to implement inclusive approaches and programs for our employees because it enhances the creative collaboration needed to develop solutions for patients.”

To qualify for Seramount’s Inclusion Index, organizations provided data and were measured in three key areas: best practices in the recruitment, retention, and advancement of people from underrepresented groups—women, racial/ethnic minorities, people with disabilities, and LGBTQ+ people; inclusive corporate culture, including leadership accountability; and demographic diversity for women and racial/ethnic minorities.

Horizon’s efforts to build and maintain an inclusive culture includes its commitment to pay equity, use of a comprehensive cultural navigation tool to enhance understanding of personal culture preferences and an annual Day of Understanding open to all employees to listen to racially and ethnically diverse experiences from their colleagues. Other programming includes unconscious bias training for all employees, resource groups specifically for women and an Employee Sponsorship Program which supports the development of our Hispanic and Black employees through a year-long program, among other programming to elevate cultural and gender diversity at all levels.

Horizon is a perennially award-winning company that has been recognized more than 65 times since 2015 for its workplace and culture. These awards are based on a combination of independent employee feedback and self-reported data from the company.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

About Seramount

Seramount, part of EAB, is a strategic professional services and research firm dedicated to advancing diversity, equity, and inclusion (DEI) in the workplace. For over four decades we have partnered with 450 of the most iconic companies in the world. This has allowed us to build a deep, data-driven understanding of the employee experience, which lays the groundwork for everything we do. Seramount provides best practice research, leadership skill-building, expert advisory and custom research, and implementation tools to DEI leaders within the organizations it serves. We meet each partner’s needs no matter where they are on their journey and guide them along an ever-changing talent landscape. Learn more at seramount.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.